CDNA vs BLLN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 19, 2026
CDNA
BLLN
Investment Advisor Scores
BLLN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CDNA | BLLN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 156.25 | 62.8931 | BLLN |
| PEG Ratio | -0.12 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 52.2% | 64.4% | BLLN |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 31.0/100 | 39.5/100 | BLLN |
| Profit Margin | 24.2% | 8.3% | CDNA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CDNA
MarkupPrice above SMA50, rising 50-day trend (24.8% over 20 days), RSI 81
BLLN
DistributionPrice near a flattening SMA50 (slope -5.3%) with fading momentum, RSI 50
Fundamentals Snapshot
| Metric | CDNA | BLLN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 51.3 | 71.2 |
| Trailing P/E | 30.8 | 149.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.5% | 0.6% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | 0.0% | 0.1% |
| EPS | 2.11 | 0.71 |
| Dividend Yield | — | — |